Cost-Efficient Transcriptomic-Based Drug Screening

Jacqueline Leidner; Heidi Theis; Michael Kraut; Alice Ragogna; Marc Beyer; Joachim Schultze; Jonas Schulte-Schrepping; Caterina Carraro; Lorenzo Bonaguro

doi:10.3791/65930

Transcriptome Profiling for High-Throughput Drug Screening

February 23, 2024

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

01:10 min

•

Drug Screening Using Peripheral Blood Mononuclear Cells (PBMCs) and Cell Lysate Preparation for mRNA Sequencing

01:56 min

•

CDNA Library Preparation from the Drug Treated-Peripheral Blood Mononuclear Cell (PBMC) Lysate for mRNA Sequencing

02:34 min

•

MRNA Sequencing to Understand the Cellular Effect of Drug Treatment

01:11 min

•

Jacqueline Leidner², Heidi Theis, Michael Kraut, Alice Ragogna, Marc Beyer^3,4, Joachim Schultze^2,3, Jonas Schulte-Schrepping², Caterina Carraro², Lorenzo Bonaguro²

¹Systems Medicine,German Center for Neurodegenerative Diseases (DZNE) eV., ²Genomics & Immunoregulation, LIMES Institute,University of Bonn, ³PRECISE Platform for Single Cell Genomics and Epigenomics,DZNE and University of Bonn, ⁴Immunogenomics & Neurodegeneration,German Center for Neurodegenerative Diseases (DZNE) eV.

Summary

This protocol describes a workflow from ex vivo or in vitro cell cultures to transcriptomic data pre-processing for cost-effective transcriptome-based drug screening.

Transcriptome Profiling for High-Throughput Drug Screening

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Drug Screening Using Peripheral Blood Mononuclear Cells (PBMCs) and Cell Lysate Preparation for mRNA Sequencing

CDNA Library Preparation from the Drug Treated-Peripheral Blood Mononuclear Cell (PBMC) Lysate for mRNA Sequencing

MRNA Sequencing to Understand the Cellular Effect of Drug Treatment

Summary

Article